CPX-351: Completed Phase IIb enrollment

Celator completed enrollment of 120 patients with AML at first relapse in the open-label, international Phase IIb CLTR0308-205 trial to compare 100 units/m 2 CPX-351 given as a 90-minute infusion on d...